ArticleBiological procedures online2025
Rap2B-mediated reprogramming of the PI3K/AKT signaling axis drives resistance to cetuximab-targeted therapy in colorectal carcinoma.
Shanshan Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.